Ambalal Sarabhai [AMBALALSA] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison

Ambalal Sarabhai Enterprises Ltd.

BSE
Loading...

Divi's Laboratories Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Ambalal Sarabhai Enterprises Ltd. wins in 7 metrics, Divi's Laboratories Ltd. wins in 12 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ambalal Sarabhai Enterprises Ltd. Divi's Laboratories Ltd. Better
P/E Ratio (TTM) 23.36 67.11 Ambalal Sarabhai Enterprises Ltd.
Price-to-Book Ratio 1.72 10.82 Ambalal Sarabhai Enterprises Ltd.
Debt-to-Equity Ratio 31.59 0.58 Divi's Laboratories Ltd.
PEG Ratio 0.62 4.63 Ambalal Sarabhai Enterprises Ltd.
EV/EBITDA 12.52 48.63 Ambalal Sarabhai Enterprises Ltd.
Profit Margin (TTM) 5.16% 24.04% Divi's Laboratories Ltd.
Operating Margin (TTM) 10.95% 29.65% Divi's Laboratories Ltd.
EBITDA Margin (TTM) 10.95% 29.65% Divi's Laboratories Ltd.
Return on Equity 3.52% 14.64% Divi's Laboratories Ltd.
Return on Assets (TTM) 1.83% 12.94% Divi's Laboratories Ltd.
Free Cash Flow (TTM) $-203.34M $2.15B Divi's Laboratories Ltd.
Dividend Yield N/A 0.91% N/A
1-Year Return -5.76% 0.83% Divi's Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.20 16.18 Ambalal Sarabhai Enterprises Ltd.
Enterprise Value $2.77B $1,635.46B Divi's Laboratories Ltd.
EV/Revenue Ratio 1.36 15.86 Ambalal Sarabhai Enterprises Ltd.
Gross Profit Margin (TTM) 41.99% 63.71% Divi's Laboratories Ltd.
Revenue per Share (TTM) $26 $388 Divi's Laboratories Ltd.
Earnings per Share (Diluted) $1.36 $93.66 Divi's Laboratories Ltd.
Beta (Stock Volatility) -0.14 0.19 Ambalal Sarabhai Enterprises Ltd.

Ambalal Sarabhai Enterprises Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis

Loading Price Chart...

AMBALALSA
DIVISLAB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ambalal Sarabhai Enterprises Ltd.-3.15%14.81%14.78%47.15%31.73%28.76%
Divi's Laboratories Ltd.0.67%-3.26%-1.31%2.02%1.80%2.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ambalal Sarabhai Enterprises Ltd.-5.76%68.27%-36.94%323.87%381.00%225.94%
Divi's Laboratories Ltd.0.83%89.86%56.44%484.44%1,625.50%9,907.51%

Performance & Financial Health Analysis: Ambalal Sarabhai Enterprises Ltd. vs Divi's Laboratories Ltd.

MetricAMBALALSADIVISLAB
Market Information
Market Cap i₹2.43B₹1.69T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i84,061253,443
90 Day Avg. Volume i120,526283,911
Last Close₹36.03₹6,576.50
52 Week Range₹23.12 - ₹38.85₹5,636.50 - ₹7,071.50
% from 52W High-7.26%-7.00%
All-Time High₹77.70 (Jul 08, 2024)₹7,071.50 (Jul 08, 2025)
% from All-Time High-53.63%-7.00%
Growth Metrics
Quarterly Revenue Growth0.13%0.12%
Quarterly Earnings Growth0.37%-0.01%
Financial Health
Profit Margin (TTM) i0.05%0.24%
Operating Margin (TTM) i0.11%0.30%
Return on Equity (TTM) i0.04%0.15%
Debt to Equity (MRQ) i31.590.58
Cash & Liquidity
Book Value per Share (MRQ)₹18.44₹580.95
Cash per Share (MRQ)₹1.73₹122.95
Operating Cash Flow (TTM) i₹-299,709,000₹19.67B
Levered Free Cash Flow (TTM) i₹49.31M₹21.91B
Dividends
Last 12-Month Dividend Yield iN/A0.91%
Last 12-Month Dividend iN/A₹60.00

Valuation & Enterprise Metrics Analysis: Ambalal Sarabhai Enterprises Ltd. vs Divi's Laboratories Ltd.

MetricAMBALALSA (Apr 24, 2026)DIVISLAB (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i23.3667.11
Forward P/E iN/A53.75
PEG Ratio i0.624.63
Price to Sales (TTM) i1.2016.18
Price to Book (MRQ) i1.7210.82
Market Capitalization
Market Capitalization i₹2.43B₹1.69T
Enterprise Value i₹2.77B₹1.64T
Enterprise Value Metrics
Enterprise to Revenue i1.3615.86
Enterprise to EBITDA i12.5248.63
Risk & Other Metrics
Beta i-0.140.19
Book Value per Share (MRQ) i₹18.44₹580.95

Financial Statements Comparison: Ambalal Sarabhai Enterprises Ltd. vs Divi's Laboratories Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAMBALALSA (2025)DIVISLAB (2025)
Revenue/Sales i1.95B93.25B
Cost of Goods Sold i1.23B38.70B
COGS % of Revenue i62.9%41.5%
Gross Profit i723.71M54.55B
Gross Margin i37.1%58.5%
Research & Development i165,000270.00M
Operating Income (EBIT) i92.36M25.71B
Operating Margin i4.7%27.6%
EBITDA i205.00M33.19B
EBITDA Margin i10.5%35.6%
Pre-Tax Income i48.34M29.16B
Pre-Tax Income % of Revenue i2.5%31.3%
Income Tax i-981,0007.25B
Income Tax % of Revenue i-0.1%7.8%
Net Income (Profit) i49.32M21.91B
Profit Margin i2.5%23.5%

Balance Sheet & Liquidity Metrics

MetricAMBALALSA (2025)DIVISLAB (2025)
Cash & Equivalents i48.95M4.15B
Total Current Assets i1.18B100.81B
Total Current Assets % of Revenue i60.7%108.1%
Total Current Liabilities i1.20B14.52B
Total Current Liabilities % of Revenue i61.6%15.6%
Long-Term Debt i90.15M20.00M
Long-Term Debt % of Revenue i4.6%0.0%
Total Shareholders Equity i1.40B149.69B
Retained Earnings i-28.33M134.00B
Retained Earnings % of Revenue i-1.5%143.7%
Property, Plant & Equipment i50.63M3.19B

Cash Flow Statement Comparison

MetricAMBALALSA (2025)DIVISLAB (2025)
Operating Cash Flow i-299.71M19.67B
Operating Cash Flow % of Revenue i-15.3%21.1%
Capital Expenditures i-25.45M-14.38B
Free Cash Flow i-203.34M2.15B
FCF Margin i-10.4%2.3%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAMBALALSADIVISLAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i76.63M265.47M
Float Shares i46.90M117.72M
% Held by Insiders i34.99%52.04%
% Held by Institutions i0.00%28.65%
% Held by Public i65.01%19.31%

Dividend Analysis & Yield Comparison: Ambalal Sarabhai Enterprises Ltd. vs Divi's Laboratories Ltd.

MetricAMBALALSADIVISLAB
Last 12-Month Dividend iN/A₹60.00
Last 12-Month Dividend Yield iN/A0.91%
3-Year Avg Annual Dividend iN/A₹50.00
3-Year Avg Dividend Yield iN/A0.70%
3-Year Total Dividends iN/A₹150.00
Ex-Dividend DateN/AJul 25, 2025